Preterm infants are currently supported with 5-8 cmH2O continuous positivie airway pressure (CPAP) at birth. This pressure range is predominantly extrapolated from CPAP support later on the... Show morePreterm infants are currently supported with 5-8 cmH2O continuous positivie airway pressure (CPAP) at birth. This pressure range is predominantly extrapolated from CPAP support later on the neonatal intensive care unit, while the underlying physiology during the transition at birth is considarably different. Based on literature- and retrospective studies, we hyptothesized that preterm infants may benefit from physiological-based (PB)-CPAP, wherein CPAP levels change following the pulmonary physiological changes during transition. PB-CPAP consists of an initial 15 cmH2O CPAP that promotes lung aeration, but that is later decreased to 8 cmH2O CPAP to maintain lung aeration. In animal studies, we demonstrated that PB-CPAP improves lung aeration and decreases the risk of apnea, without causing lung over-expansion when CPAP levels are decreased appropriately. In a randomized trial, we showed that PB-CPAP improves heart rates of preterm infants when compared to 5-8 cmH2O, which also implies improved lung aeration. Despite its benefits, the current PB-CPAP strategy is too complex for caregivers to combine with standard care. Future studies will focus on automatization or simplification of PB-CPAP to improve CPAP support for preterm infants at birth. Show less
Background: Preterm infants are commonly supported with 5-8 cmH(2)O CPAP. However, animal studies demonstrate that high initial CPAP levels (12-15 cmH(2)O) which are then reduced (termed... Show moreBackground: Preterm infants are commonly supported with 5-8 cmH(2)O CPAP. However, animal studies demonstrate that high initial CPAP levels (12-15 cmH(2)O) which are then reduced (termed physiological based (PB)-CPAP), improve lung aeration without adversely affecting cardiovascular function. We investigated the feasibility of PB-CPAP and the effect in preterm infants at birth.Methods: Preterm infants (24-30 weeks gestation) were randomized to PB-CPAP or 5-8 cmH(2)O CPAP for the first 10 min after birth. PB-CPAP consisted of 15 cmH(2)O CPAP that was decreased when infants were stabilized (heart rate >= 100 bpm, SpO(2) >= 85%, FiO(2) <= 0.4, spontaneous breathing) to 8 cmH(2)O with steps of ~2/3 cmH(2)O/min. Primary outcomes were feasibility and SpO(2) in the first 5 min after birth. Secondary outcomes included physiological and breathing parameters and short-term neonatal outcomes. Planned enrollment was 42 infants.Results: The trial was stopped after enrolling 31 infants due to a low inclusion rate and recent changes in the local resuscitation guideline that conflict with the study protocol. Measurements were available for analysis in 28 infants (PB-CPAP n = 8, 5-8 cmH(2)O n = 20). Protocol deviations in the PB-CPAP group included one infant receiving 3 inflations with 15 cmH(2)O PEEP and two infants in which CPAP levels were decreased faster than described in the study protocol. In the 5-8 cmH(2)O CPAP group, three infants received 4, 10, and 12 cmH(2)O CPAP. During evaluations, caregivers indicated that the current PB-CPAP protocol was difficult to execute. The SpO(2) in the first 5 min after birth was not different [61 (49-70) vs. 64 (47-74), p = 0.973]. However, infants receiving PB-CPAP achieved higher heart rates [121 (111-130) vs. 97 (82-119) bpm, p = 0.016] and duration of mask ventilation was shorter [0:42 (0:34-2:22) vs. 2:58 (1:36-6:03) min, p = 0.020]. Infants in the PB-CPAP group required 6:36 (5:49-11:03) min to stabilize, compared to 9:57 (6:58-15:06) min in the 5-8 cmH2O CPAP group (p = 0.256). There were no differences in short-term outcomes.Conclusion: Stabilization of preterm infants with PB-CPAP is feasible but tailoring CPAP appeared challenging. PB-CPAP did not lead to higher SpO(2) but increased heart rate and shortened the duration of mask ventilation, which may reflect faster lung aeration. Show less
Martherus, T.; Oberthuer, A.; Dekker, J.; Kirchgaessner, C.; Geloven, N. van; Hooper, S.B.; ... ; Pas, A.B. te 2019
